What question did this study set out to answer?

The research aims to explore how aberrant Mrs2-mediated magnesium signaling contributes to mitochondrial dysfunction in pulmonary arterial hypertension (PAH).

March 18, 2026

Enhanced Mitochondrial Mrs2-Mg 2+ Signaling Drives Mitochondrial Dysfunction in Pulmonary Arterial Hypertension Rats

Key Points

The research aims to explore how aberrant Mrs2-mediated magnesium signaling contributes to mitochondrial dysfunction in pulmonary arterial hypertension (PAH).
Investigated Mrs2-mediated magnesium signaling in a rat model of PAH.
Analyzed its effects on mitochondrial function and metabolic homeostasis.
Assessed potential therapeutic strategies targeting the ionic-metabolic axis.
Disruption of Mrs2 signaling led to significant mitochondrial dysfunction.
Found alterations in global ionic and metabolic balance in PAH rats.
Indicated that targeting Mrs2 may help in managing PAH progression.

Abstract

Aberrant Mrs2-mediated mMg2+ signaling disrupts global ionic and metabolic homeostasis, driving mitochondrial dysfunction and pathogenic remodeling in PAH. Targeting the Mrs2-centered ionic-metabolic-dynamic axis may represent a potential therapeutic approach that warrants further investigation to interrupt PAH progression.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Chen et al. (Mon,) studied this question.

synapsesocial.com/papers/69ba424e4e9516ffd37a2731 https://doi.org/https://doi.org/10.1161/hypertensionaha.126.25866

Bookmark

View Full Paper